![](/img/cover-not-exists.png)
321TiPSOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (with or without letrozole in ER+) in previously trastuzumab-pretreated, postmenopausal patients with HER2-positive metastatic breast cancer
Villagrasa Gonzalez, P., Prat, A., Oliveira, M., de la Pena, L., Gonzalez, X., Cortes Castan, J., Rios, J., Vázquez, J., Martínez Jañez, N., Perelló Martorell, A., Garau, I., Martinez de Dueñas, E., MVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx365.084
Date:
September, 2017
File:
PDF, 55 KB
english, 2017